// App-Quantinova.ai

282 : PI3Ka Inhibition Suppresses Central Nervous System Involvement of Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Hisayuki Yao

Principal Investigators

  • Trevor Price

  • Lindsey Olivere

  • Matthew Warner

  • Stacey Tannheimer

  • Dorothy A. Sipkins

Medical Centers

  • Duke University, Durham, NC

  • Depertment of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC

Locations

  • United States

Companies

  • Gilead Sciences, Inc

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Chronic Lymphocytic Leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

Drug/Treatment

  • Idelalisib

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved